Assessment and Tracking of Long-term Alefacept Safety

Safety and Tolerability of Repeat Courses of IM Alefacept

NCT00233662 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Efficacy and Safety of Alefacept in Psoriasis Patients for Whom Conventional Treatment is Ineffective or Inappropriate

NCT00673556 ·Status: COMPLETED ·Phase: PHASE3

Long-Term One Year Use of Alefacept (Amevive®) in Moderate to Severe Chronic Plaque Type Psoriasis

NCT00655564 ·Status: COMPLETED ·Phase: PHASE4

Open Label Study of Alefacept Injections to Patients With Moderate to Severe Psoriasis

NCT00678470 ·Status: COMPLETED ·Phase: NA

Clinical Trial to Investigate Efficacy of LAS41004 in Psoriasis

NCT01283698 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp

NCT03123471 ·Status: COMPLETED ·Phase: PHASE3

A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.

NCT00504270 ·Status: COMPLETED ·Phase: PHASE2

Transitioning From Cyclosporine to Alefacept in Psoriasis

NCT00143806 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis.

NCT01232283 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis

NCT03701763 ·Status: COMPLETED ·Phase: PHASE3

Topical Application of AS101 for the Treatment of Psoriasis

NCT00788424 ·Status: WITHDRAWN ·Phase: PHASE2

Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques

NCT05642182 ·Status: RECRUITING ·Phase: PHASE1

A Study of the Impact of Apremilast (CC-10004) on Quality of Life, Efficacy, and Safety in Adults With Manifestations of Plaque Psoriasis and Impaired Quality of Life

NCT03774875 ·Status: COMPLETED ·Phase: PHASE4

A Safety and Efficacy Study of Alefacept in the Treatment of Moderate to Severe Erosive Mucosal Lichen Planus

NCT00135733 ·Status: TERMINATED ·Phase: PHASE2

LAS41008 in Moderate to Severe Chronic Plaque Psoriasis

NCT01726933 ·Status: COMPLETED ·Phase: PHASE3

Alefacept (Amevive) With or Without Narrowband UVB Treatment in Patients With Psoriasis.

NCT00407342 ·Status: COMPLETED ·Phase: NA

Evaluate the Efficacy and Safety of One Course of Amevive in Taiwan Patients

NCT00422617 ·Status: COMPLETED ·Phase: NA

Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque Psoriasis

NCT00090129 ·Status: TERMINATED ·Phase: PHASE3

Assess the Efficacy and Safety of Alefacept With Narrow Band Ultraviolet B Phototherapy (nbUVB) vs. Alefacept Alone in Chronic Plaque Psoriasis Subjects

NCT00658606 ·Status: COMPLETED ·Phase: PHASE4

Study to Investigate Dose-related Efficacy of LAS41004 in the Treatment of Psoriasis

NCT01119339 ·Status: COMPLETED ·Phase: PHASE2

A Study of Treatment With APRemilast in Moderate psoriAsIS in Real Life clinicAL Practice (The 'APRAISAL' Study)

NCT03059953 ·Status: COMPLETED

Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions (2)

NCT00625157 ·Status: COMPLETED ·Phase: PHASE2

Pilot Study of Apremilast (CC-10004) in the Treatment of Moderate to Severe Lichen Planus

NCT01041625 ·Status: UNKNOWN ·Phase: PHASE2

Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis

NCT01194219 ·Status: COMPLETED ·Phase: PHASE3

A Study of Real-World Experience of Psoriasis Patients Treated With Apremilast in Clinical Dermatology Practice

NCT02740218 ·Status: COMPLETED